Increased risk of recurrent venous thromboembolism during hormone replacement therapy. Results of the randomized, double-blind, placebo controlled estrogen in venous thromboembolism trial (EVTET) - Hoibraaten,E.; Qvigstad,E.; Arnesen,H. (Thromb Haemost, 2000)